Results 131 to 140 of about 5,449 (190)

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? [PDF]

JAC Antimicrob Resist
Assimakopoulos SF, Ioannou S, Rodriguez-Bano J, Marangos M, Daikos GL.   +4 more
europepmc   +1 more source

Influence of iron uptake systems on cefiderocol activity in <i>Escherichia coli</i>: At the crossroads of antibiotic resistance and virulence. [PDF]

Antimicrob Agents Chemother
Mallecot E, Berti V, Petitjean M, Meyer J, Gueye S, Morel-Journel T, Timsit S, Clermont O, Poirel L, Denamur E, Royer G, Armand-Lefevre L.   +11 more
europepmc   +1 more source

Case Commentary: When susceptibility is not enough in recurrent <i>Burkholderia cenocepacia</i> infection. [PDF]

Antimicrob Agents Chemother
Giuliano S, Gaibani P, Tascini C.
europepmc   +1 more source

Cefiderocol Targeted Treatment for Multidrug-Resistant Gram-Negative Infections: An Observational Cohort Study. [PDF]

Antibiotics (Basel)
García-Carnero L, Abelenda-Alonso G, Santos-Puig M, Padullés A, Ribera C, Lamiel A, Costa-Primo R, Aledo MG, Granada R, Gumucio VD, Santafosta E, Gilabert M, Blanco-Arévalo A, Puig-Asensio M, Shaw E, Carratalà J, Gudiol C.   +16 more
europepmc   +1 more source

Intrinsic resistance networks shape cefiderocol susceptibility in ST258 <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Rome KJ, Terlecky AJ, Yen KK, Long T, Bucich MJ, Thom KV, Shashkina E, Chen L, Kreiswirth BN.   +8 more
europepmc   +1 more source

Recurrence of Postneurosurgical Central Nervous System Infection Caused by <i>Acinetobacter baumannii</i> in a Critically Ill Patient Treated With Cefiderocol. A Case Report. [PDF]

Case Rep Infect Dis
Accurso G, Ancona A, Costa GM, Vitale F, Petronaci D, Corpora G, Profera L, Giarratano A, Raineri SM.   +8 more
europepmc   +1 more source

Cefiderocol Is Effective In Vitro Against Numerous Gram-Negative Species Isolated from Keratitis Patients. [PDF]

Antibiotics (Basel)
Mandell JB, Shanks RMQ, Romanowski EG.
europepmc   +1 more source

Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]

Am J Case Rep
Nuaimi M, Cirillo J, Usbosy S, Egan D, Kovacich A, Madruga M, Carlan SJ.   +6 more
europepmc   +1 more source

Impact of Susceptibility Testing Methodology on the Positioning of Cefiderocol and Aztreonam-Avibactam Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria. [PDF]

Antibiotics (Basel)
Del Nogal-Labrador F, González-Blanco B, Sanz MI, Recio R, Brañas P, Muñoz-Gallego I, Viedma E, Villa J.   +7 more
europepmc   +1 more source

Treatment Options for Metallo-Beta-Lactamase-Producing <i>Enterobacterales</i> in the Era of Increasing Resistance. [PDF]

Int J Mol Sci
Golovina A, Antipin F, Khalymbadzha I, Terina O, Yakovlev D, Fedina E, Ivanov R.   +6 more
europepmc   +1 more source